Qulipta vs. Nurtec ODT: Which CGRP Gepant Is Right for PI Patients?

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | September 23, 2025 | 8 min read

Qulipta (atogepant) and Nurtec ODT (rimegepant) are both oral CGRP gepants used for post-traumatic migraine. But they have a critical difference: only Nurtec treats both acute migraine attacks AND prevents future ones. Here's how to choose between them for personal injury patients.

Qulipta vs. Nurtec ODT: Which CGRP Gepant Is Right for Personal Injury Patients?

Post-traumatic migraine is one of the most common and most underestimated consequences of personal injury. When a physician prescribes a CGRP gepant for a PI patient, they're choosing between two oral options: Qulipta (atogepant) and Nurtec ODT (rimegepant). Both work through the same mechanism — blocking the CGRP receptor that triggers migraine — but their FDA approvals, dosing schedules, and clinical utility differ significantly.

Understanding the difference matters for attorneys building a damages narrative, and for clinicians selecting the right tool for the individual patient.

[!KEY] Qulipta is a daily preventive only; Nurtec ODT is the only CGRP gepant approved for both acute treatment and prevention — the clinical choice between them documents the specific pattern of the patient's post-traumatic migraine burden.

[!SOURCE] FDA CGRP Drug Approvals — FDA-approved CGRP antagonists for migraine prevention and treatment.

The Core Difference: Preventive Only vs. Preventive + Acute

This is the most important distinction:

Qulipta is a dedicated preventive — taken every day to reduce the frequency of migraine attacks. Nurtec ODT carries FDA approval for both acute treatment and prevention — the same 75mg ODT can stop an active migraine or, taken every other day, reduce how often migraines occur.

When Physicians Choose Qulipta

Qulipta is the right choice when:

• The clinical goal is pure prevention with consistent daily dosing
• The patient is being managed on a clear regimen and will also use a separate acute rescue medication (a triptan, ubrogepant, or lasmiditan) for breakthrough attacks
• Higher-dose prevention is needed — the 60mg dose showed the strongest preventive efficacy in clinical trials, approximately 55-61% reduction in migraine days per month
• The patient prefers the simplicity of a once-daily tablet

The three available doses (10mg, 30mg, 60mg) allow titration based on tolerability and clinical response. Physicians treating patients with high migraine frequency from head trauma may prefer the higher-dose Qulipta options.

Qulipta in the PI Record

A Qulipta prescription documents:

• Physician-diagnosed migraine disorder requiring daily preventive pharmacotherapy
• A decision to use an FDA-approved CGRP-class preventive rather than older agents with more side effects
• Chronic migraine management with a specific CGRP-mechanism drug, distinguishing this from simple headache

When Physicians Choose Nurtec ODT

Nurtec ODT is the right choice when:

• The patient needs both acute and preventive coverage in a single medication — they have unpredictable migraine attacks requiring on-demand treatment, AND they need preventive therapy
• The orally disintegrating formulation is advantageous — patients with migraine-associated nausea or difficulty swallowing during attacks benefit from a tablet that dissolves on the tongue without water
• The patient may not tolerate the daily dosing commitment of Qulipta and would benefit from the every-other-day prevention schedule
• The physician wants to simplify the medication regimen — one drug for two functions reduces pill burden

Nurtec in the PI Record

A Nurtec ODT prescription for both acute and preventive use documents:

• Migraine attacks occurring frequently enough to require both acute rescue and preventive treatment
• Clinical selection of an FDA-approved dual-indication treatment
• Chronic migraine management extending beyond the immediate post-injury period

The dual-indication prescription — when the provider notes that Nurtec is being used for both purposes — creates a particularly strong record of migraine severity: the patient has attacks that need to be treated when they occur AND occur frequently enough to require prevention.

[!KEY] A Nurtec ODT prescription used for both acute and preventive migraine is among the most powerful single-medication records in a PI demand — it simultaneously documents migraine attacks severe enough to require immediate treatment and a migraine frequency high enough to warrant daily prevention, all in one prescription.

Clinical Consideration: Concurrent Use

Qulipta and Nurtec should not be used simultaneously — both block CGRP receptors, and using two CGRP-mechanism drugs together provides no additional benefit and increases the risk of side effects. When Nurtec is used for prevention, it can also serve as the acute rescue medication, eliminating the need for Qulipta.

Physicians treating PI patients on injectable CGRP monoclonal antibodies (Aimovig, Emgality, Ajovy, or Vyepti) may also add an oral gepant for acute attacks — the antibodies prevent; the gepant treats breakthroughs.

Side Effect Profile: Both Are Well-Tolerated

Both atogepant and rimegepant have favorable tolerability compared to older preventive medications:

Qulipta (atogepant):

• Nausea (most common)
• Constipation
• Fatigue

Nurtec ODT (rimegepant):

• Nausea
• Urinary tract infection (mild, possibly related to CGRP receptor activity in the kidney)
• Generally very well-tolerated even at the first dose

Neither medication causes the weight gain, cognitive effects ("brain fog"), hair loss, or mood changes associated with older preventive agents like valproate, amitriptyline, or topiramate. This tolerability supports long-term PI treatment without impairing the patient's ability to function, work, or participate in their legal case.

What Attorneys Should Know

Both Document Chronic, Post-Traumatic Migraine

Whether the prescriber chose Qulipta or Nurtec ODT, the prescription reflects the same clinical reality: the patient has been diagnosed with a migraine disorder significant enough to require preventive pharmacotherapy with a modern CGRP-class medication. That diagnosis is a documented injury consequence.

The Drug Class Matters

The shift from older preventive agents (which were originally developed for other conditions — depression, blood pressure, epilepsy) to purpose-built CGRP antagonists reflects the advancement of migraine medicine. A CGRP gepant prescription demonstrates that the treating physician is actively managing a clinically significant migraine condition with state-of-the-art therapy.

Prevention = Ongoing Injury Management

A preventive medication — by definition — is a long-duration treatment. A patient who needs daily Qulipta or every-other-day Nurtec is managing a chronic migraine condition. Monthly refills document ongoing, unresolved injury consequences affecting the patient's daily life.

[!KEY] The shift from older migraine preventives — originally developed for blood pressure, epilepsy, or depression — to purpose-built CGRP antagonists signals that the treating neurologist is applying state-of-the-art migraine science to this patient's case, which makes it harder for defense experts to argue the treatment was excessive or unrelated to the injury.

Summary

For personal injury patients with post-traumatic migraine, both represent strong clinical choices — the selection depends on whether the treating physician prioritizes maximum preventive dosing flexibility (Qulipta) or combined acute + preventive utility in a single agent (Nurtec ODT).

LienScripts provides pharmacy lien coverage for both Qulipta and Nurtec ODT at $0 upfront cost for qualified personal injury patients. For questions about CGRP coverage or to discuss a specific patient, contact LienScripts.

Related Resources

• CGRP Medications for Post-Traumatic Migraine in Personal Injury Cases
• Aimovig, Emgality, Ajovy, and Vyepti: Injectable CGRP Antibodies for PI
• Why PI Patients Often Need Multiple Medications
• Pharmacy Services for Personal Injury Clients: How It Works
• What Are Medication Liens?